Your browser doesn't support javascript.
loading
Mocetinostat in Combination With Durvalumab for Patients With Advanced NSCLC: Results From a Phase I/II Study.
Johnson, Melissa L; Strauss, James; Patel, Manish R; Garon, Edward B; Eaton, Keith D; Neskorik, Tavette; Morin, Josée; Chao, Richard; Halmos, Balazs.
Affiliation
  • Johnson ML; Medical Oncology, Sarah Cannon Research Institute, Nashville, TN.
  • Strauss J; Mary Crowley Cancer Research, Dallas, TX.
  • Patel MR; Department of Medicine, Division of Hematology, Oncology, and Transplantation, University of Minnesota Masonic Cancer Center, Minneapolis, MN.
  • Garon EB; Department of Medicine, David Geffen School of Medicine at UCLA, Santa Monica, CA.
  • Eaton KD; Department of Medicine, Division of Medical Oncology, University of Washington and Fred Hutchinson Cancer Center, Seattle WA.
  • Neskorik T; Innovative Medicines Development, Mirati Therapeutics Inc., San Diego, CA.
  • Morin J; Innovative Medicines Development, Mirati Therapeutics Inc., San Diego, CA.
  • Chao R; Innovative Medicines Development, Mirati Therapeutics Inc., San Diego, CA.
  • Halmos B; Department of Oncology, Montefiore Medical Center, Bronx, NY. Electronic address: bahalmos@montefiore.org.
Clin Lung Cancer ; 24(3): 218-227, 2023 05.
Article in En | MEDLINE | ID: mdl-36890020

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Limits: Humans Language: En Journal: Clin Lung Cancer Journal subject: NEOPLASIAS Year: 2023 Document type: Article Affiliation country: Tunisia Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Limits: Humans Language: En Journal: Clin Lung Cancer Journal subject: NEOPLASIAS Year: 2023 Document type: Article Affiliation country: Tunisia Country of publication: United States